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ABSTRACT 
In this review, the authors have discussed scientific advances in thermosensitive hydrogels over the past two decades. The ability of the thermo-
sensitive hydrogel to undergo rapid changes with response to temperature makes it an attractive candidate for many biomedical applications such 
as targeted drug delivery, wound healing, soft contact lenses, sensors, tissue regeneration, gene, and protein delivery. This review aims to deliver a 
brief overview of gelation properties, merits, and demerits of various natural and synthetic thermo-sensitive polymers that have significant clinical 
relevance. The report emphasizes the importance of injectable thermosensitive hydrogels, as it can offer improved solubility of hydrophobic drugs 
and site-specificity, extended-release of drugs and macromolecules, improved safety, and local administration of drugs. The authors has also 
provided a commentary on the delivery of drugs or macromolecules from thermo-sensitive hydrogels through various approaches. This review 
highlights the current status of research in thermo-sensitive hydrogels and emphasizes the importance of developing nontoxic thermo-sensitive 
hydrogels, dual responsive, and multi-responsive hydrogel systems.  
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INTRODUCTION 
Hydrogels are water-insoluble, randomly cross-linked three-
dimensional polymeric systems that have an incredible capability to 
swell and retain a significant amount of water within their structural 
framework. The water molecules entrapped into the hydrogel network 
crosslinks the macromolecules through physical or chemical means [1, 
2]. The basic properties of hydrogels are can be brought under 
mechanical properties, biocompatibility properties, and swelling 
properties [3]. Hydrogels containing nanoparticles should be used to 
optimize the thermal, mechanical, optical, and chemical properties of 
the hydrogel [4]. Physical cross-linking of hydrogels results from weak 
interactions such as hydrogen bonds, hydrophilic/hydrophobic 
interactions, ionic/electrostatic interactions, reversible intermolecular 
interactions, stereo-complex formation, metal coordination, π-π 
stacking, and polymerized entanglements. The physically cross-linked 
hydrogels can be easily disrupted by adding organic solvents or by 
changing the ionic strength, pH, or temperature owing to their weak 
cross-linking interaction. Chemical crosslinking results in the 
formation of stable hydrogel with considerable mechanical strength 
and are usually created by photo-polymerization; Diels-Alder clicks 
reaction, Michael type addition, oxime formation, Schiff base 
formation, and enzyme-induced crosslinks [2, 5]. Placing hydrophilic 
groups such as amides, sulfonic acids, hydroxyl groups, and carboxylic 
acids into the structure, hydrogels can absorb large amounts of water 
and form hydrophilic polymers [6]. It can be added through novel 
mechanisms that can be used to improve the physical properties of the 
hydrogel [7]. Hydrogels are biocompatible and biodegradable, 
resembling natural tissues due to their high flexibility and high 
moisture content. Hydrogels offer good transport properties, making 
them a potential drug delivery carrier to achieve timed release of 
drugs or nutrients [8]. Hydrogel has gained a special interest among 
the biomedical community due to their extensive property and their 
resemblance with the extracellular matrix [9]. Useful applications of 
hydrogels include drug delivery devices and wound dressings [10, 11]. 
Some of the limitations associated with hydrogels are lower 
mechanical strength, difficulty to handle, and difficult to load with 
nutrients or drugs. To overcome these limitations, smart hydrogels are 
developed [12]. 
In this review, the authors have delved into the scientific 
developments of thermosensitive hydrogels during the past two 
decades. The major focus was the newer thermosensitive hydrogels 
and advances in their applications as a tool in targeted and 
prolonged-release drug delivery. Thermo-sensitive hydrogels have 
received considerable attention due to their ease of application, 
simplicity of drug formulation, less antagonistic effect on tissues, 
protective environment for drugs, localized drug delivery, and other 
attractive gelling systems [13]. Depending on thermo-sensitive 
groups present, the formation of thermo-sensitive hydrogels 
momentarily happens by a microscopic mechanism when the 
gelation temperature is attained. The solid phase is separated from 
the solution near the critical temperature [14]. Thermo-sensitive 
hydrogels can be classified into negatively thermo-sensitive and 
positively thermo-sensitive hydrogels. Negatively thermo-sensitive 
hydrogels are formed by LCST polymers, whereas positively thermo-
sensitive hydrogels are formed by UCST polymers [15]. At lower 
consolute temperature or lower critical solution temperature 
(LCST), the polymer becomes hydrophobic and shrinks due to 
change in the phase from soluble random coil to insoluble globule 
structure. The inherent LCST can be modified by changing the 
hydrophilic/hydrophobic ratio. In contrast, upper consolute 
temperature or upper critical solution temperature (UCST) 
polymers are enthalpy driven, which swells with heating and turns 
soluble in an aqueous system due to dissociation of interpolymer 
complex [16]. The sol-gel properties of thermosensitive hydrogels 
are non-invasive because they can liquefy the hydrogel almost 
anywhere in the CNS. Viscous hydrogels form a sustained-release 
reservoir of the therapeutic agent at body temperature. It can also 
be filled with a variety of drugs, including neuroprotective agents, 
neurotrophic factors, chemotherapeutic agents, and cells [17]. In 
certain physiological conditions, the in-situ (gel) delivery system 
involves the change of liquid state of the formulation into a gel at the 
site of application. Many factors regulate the gelation in the field, 
viz., temperature, pH, solvent exchange, ion crosslinking, and UV 
light [18]. The sol-gel transition of hydrogels is determined using 
various testing strategies, including cloud and pour point estimation, 
rheological properties, and differential scanning calorimeter (DSC) 
[19-22]. In-situ delivery systems can significantly reduce the 
concentration and frequency of the daily dose, patient compliance, 
improving bioavailability and cost-effectiveness [23].  
The characteristic phase transition of polymers enables the 
development of smart medicated formulations such as splash, 
injectable, and shaped hydrogels which retain the drug at the site of 
utilization over a longer period [24]. The thermosensitive drug 
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delivery system depends on the temperature change to release its 
payload through dissolution, diffusion, disintegration, and erosion 
mechanism [25]. An ideal thermosensitive hydrogel drug delivery 
system should stream freely at ambient temperature and transform 
into a non-streaming gel at physiological temperature (32 °C-37 °C) 
[24]. This demands the development of in-situ hydrogel, which can 
readily arrange and harden inside the body with negligible protrusion 
[26]. The injectable thermosensitive hydrogel has gained special 
interest as it can offer improved solubility of hydrophobic 
medications, site-specificity, sustained-release behavior, delivery of 
drugs and macromolecules including protein, peptide, nucleic acid 
improved safety, etc [24], local administration to avoid the first-pass 
metabolism and easily administered without surgical procedure [27]. 
Some of the limitations associated with the system include increased 
surgical risk associated with device implantation/retrieval and 
chances of clogging inside the body immediately after injection [28]. 
The purpose of this review is to provide an overview of 
thermosensitive hydrogels, important thermosensitive materials, drug 
delivery approaches, and applications of thermosensitive hydrogels.  
Thermosensitive polymers 
Thermosensitive or thermo-responsive polymers undergo 
macroscopic changes in the aqueous medium when lower critical 
solution temperature or upper critical solution temperature is 
reached. The thermosensitive polymers are mainly categorized into 
natural and synthetic polymers.  
Natural polymers 
Natural polymers were widely studied because of their non-toxicity, 
biocompatibility, biodegradability, and low inflammatory response 
similar to that of host tissue. However, these polymers present 
immunological concerns, batch to batch variation, and difficulty in 
purification. The natural polymers can be easily modified to obtain a 
wide variety of applications. Interestingly, numerous researchers obtain 
hydrogels by combining natural polymers with synthetic polymers. The 
most commonly used natural thermo-responsive polymers are 
categorized into polysaccharides (Cellulose derivative, Chitosan, 
Dextran, Xyloglucan) and proteins (gelatin, collagen, and albumin) [29].  
a. Cellulose and cellulose derivative 
Cellulose is a naturally occurring water-insoluble polymer that has a 
greater degree of hydrophilicity on its chain structure. The 
insolubility of this highly hydrophilic cellulose is mainly due to the 
formation of strong intermolecular hydrogen bonds. The aqueous 
solubility of cellulose can be achieved by substitution of a certain 
fraction of hydroxyl groups by hydrophobic groups such as hydroxyl 
propyl groups or methyl groups, which in turn disrupts the 
intermolecular hydrogen bonds. Complete substitution of hydroxyl 
groups with hydrophobic moieties renders the cellulose insoluble 
[30]. Depending on the degree of substitution, the thermo-
reversibility of methylcellulose can take place in the temperature 
range from 60 ° to 80 °C [31]. The LCST of methylcellulose hydrogels 
can be adjusted to physiological temperature by grafting it with 
other monomers. Liu et al., grafted methylcellulose with N-isopropyl 
acrylamide (NIPAM) in various ratios to adjust the LCST to the 
desired temperature [32]. The PNIPAM grafted with lower levels of 
methylcellulose decreased the LCST, whereas at higher levels the 
LCST increases. The inclusion of methylcellulose into the PNIPAM 
structure enhanced the mechanical stability of the gel without 
expulsion of the liquid. The higher LCST of cellulose derivatives 
limits their usage as thermo-sensitive gels. However, they are 
utilized as controllers to tune the other thermo-sensitive polymeric 
system to attain the desired LCST. 
b. Chitosan 
Chitosan, also known as Poliglusamis a natural poly-cationic linear 
oligosaccharide derived from chitin by alkaline hydrolysis. They are 
composed of randomly distributed acetylated and deacetylated D-
glucosamine units bound with each other through 1→4 glycosidic 
linkages. The chitosan polymeric chains have many amine groups (-
NH2
Chenite et al. (2000) were the first to explore the thermo-sensitive 
behavior of chitosan modified with glycerophosphate [37]. The 
gelation temperature remains unchanged with a varying molecular 
weight of chitosan, whereas it is greatly influenced by the 
concentration of glycerophosphate when the concentration and level 
of deacetylation of chitosan remain constant. The gelation 
temperature of the chitosan can be reduced with increasing 
concentration of the glycerophosphate [38, 39]. Following Chenite et 
al. significant advancement, several researchers were involved in the 
development of thermo-sensitive hydrogels on natural polymers. The 
mechanism of gelation involved in thermo-responsive 
chitosan/polyol-phosphate system has been demonstrated by Nicolas 
Anton et al. They stated that a hydration defensive layer of polyols is 
held around the chitosan through weak intermolecular hydrogen 
bonding; any increase in temperature disrupts the hydrogen bonding 
of polymer and induces gelation through stronger hydrophobic 
interactions [40, 41]. Bhattarai et al. produced a thermoreversible 
hydrogel using polyethylene glycol and chitosan without the addition 
of a crosslinking agent [41]. Nazar et al. synthesized N-trimethyl 
chitosan chloride/polyethylene glycol/glycerophosphate hydrogels for 
nasal drug delivery, showing a thermoreversible behavior at 35 °C 
[42]. Though chitosan has lower mechanical strength, it is broadly 
utilized in the development of thermo-sensitive hydrogel systems. 
) and hydroxyl groups (-OH) [33, 34]. The amine functional 
group of chitosan is highly reactive and allows the derivatization of 
polymers for improved properties such as bio-adhesion, 
mucoadhesion, gene transferability, high drug loading, and 
controlled drug release [29, 34]. The biodegradability, 
biocompatibility, and low toxic potential of chitosan, make it 
preferable over other natural polymers [35, 33] despite their 
limitations such as small specific surface area and void fraction [36].  
c. Xyloglucan 
Xyloglucan is non-ionic hemicellulose and a hydrophilic 
polysaccharide that carries xylose and galactosyl-xylose. They are 
abundantly found in primary cell walls and seeds of all vascular 
plants. A "mucin-like" xyloglucans obtained from tamarind seeds are 
linear β-(1 → 4)-D-glucan chain branched with (1–6)-α-xylose or (1–
2)-β–galactoxylose side chains [43-45]. Xyloglucan is digested using 
fungal β-galactosidase to eliminate approximately 35% of the 
galactose residues [46, 47]. The transition temperature of 
xyloglucans is inversely proportional to the concentration of 
polymer and the percentage of galactose residues removed [48, 49]. 
Xyloglycans undergo a phase transition at a much lower 
concentration (1 to 3% wt) compared to other thermo-sensitive 
polymers, including block polymers [50, 51]. Xyloglucans are highly 
biocompatible, biodegradable, and have high water 
absorption/retention capacity. It has drawn a considerable research 
interest in developing xyloglucan hydrogels for biomedical 
applications [52-55]. Additionally, xyloglucan hydrogels combined 
with poly D-lysine showing a phase transition under physiological 
conditions were assessed for their possibility to deliver the cells. 
Poly-D-lysine-incorporated xyloglucan hydrogels promote the repair 
of damaged neural pathways, including the axons in the central 
nervous system [56]. Derivatized xyloglucans are interconnected 
three-dimensional microporous systems that adhere to cells and 
detach when the suitable temperature is reached. The microporous 
structure of xyloglucans directs them to be a potential delivery 
vehicle in the use of regenerative medication [51, 57]. 
d. Dextran 
Dextran is a biocompatible and biodegradable polysaccharide 
obtained from the enzymatic decomposition of sugarcane. Dextran 
lacks thermosensitive behavior; however, their incorporation into 
other thermosensitive materials form thermosensitive hydrogels [58]. 
Huang et al. prepared block polymers consisting of dextran, NIPAAm, 
2-hydroxyethyl methacrylate (HEMA), oligolactate that are capable of 
forming thermosensitive hydrogels with LCST around 32 °C. Wang et 
al. demonstrated the protective effects of block polymer comprising 
dextran, Polycaprolactone, and NIPAAm or HEMA on the remodeling 
of ventricular damage caused by myocardial infarction [59].  
e. Gelatin 
Gelatin, a thermo-reversible and cold setting polymer composed of a 
mixture of peptides and denatured proteins acquired by incomplete 
hydrolysis of collagen extracted from bones and connective tissues of 
animals [60]. Gelatin appears to be semi-solid beneath UCST (35 °C), 
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as the gelatin molecules are inter and intramolecularly cross-linked by 
hydrogen bonds, forming a three-dimensional triple helix steady 
collagen supercoil structure. The cross-linking density of the gelatin is 
dependent on the number of water molecules entrapped and bound to 
NH2
Synthetic polymers 
 groups of supercoiled chains via hydrogen bonding [61, 62]. 
Gelatin undergoes conformational changes from a triple helix to a 
random coil at 40 °C, introducing a fluidic state [61]. The fluidic state 
of gelatin offers a large number of reactive functional groups, allowing 
them for modification of gelation properties [27]. Yang and Kao 
developed a hydrogel composed of poly (ethylene glycol)-poly (D, L-
lactide) block copolymer and gelatin, which flows effortlessly at 37 °C 
and remains gel at room temperature [63]. 
Synthetic thermo-sensitive polymers are biodegradable and have a 
considerable mechanical strength depending on the molecular 
weight, concentration, and ratio of molecular units. Though the LCST 
of these polymers can be easily modified to the desired temperature, 
most of these polymers are non-biocompatible and requires the 
incorporation of natural polymers for their use as thermosensitive 
injectable hydrogels [59]. 
The various thermosensitive synthetic polymers include NIPAM-
based system, PEO-PPO based system, PEG-biodegradable polyester, 
dimethylamino based system, poly (organophosphazene), pluronic 
hydrogel, PEG-polyester, Polyacrylamide derivative, 2-hydroxy ethyl 
and methyl methacrylate, trimethyl-ol-propane, trimethacrylate, 
benzoin methyl ether, polyurethane, polyvinyl pyrrolidone, PLGA, 
Poly (N, N-diethyl acrylamide), Poly (N-ethyl methacrylamide), Poly 
(methyl vinyl ether), poly (2-ethoxy ethyl vinyl ether), Poly (N-vinyl-
iso-butyramide), Poly (N-vinyl caprolactam), Poly (N-(2-hydroxy 
propyl) methacrylamide mono/dilactate), Poly (acrylic acid-co-
acrylamide), poly-ethers, Poly (alkyl oxide) copolymers, C Pluronic 
F-127, Poly (Dimethylamino ethyl methacrylate) [64-68]. 
Thermoresponsive synthetic polymers are generally amphiphilic tri-
blocks of poly (ethylene oxide) (PEO), poly (propylene oxide) (PPO), 
poly-lactic acid (PLA), Poly (D, L–lactic acid (CO-glycolic acid)) 
(PLGA), poly (e-caprolactone) (PCL) and polyethylene glycol (PEG). 
a. NIPAM based polymer 
N-Isopropylacrylamide based hydrogels are the most widely 
investigated thermosensitive system. The homopolymer and 
copolymers of Poly (N-isopropyl acrylamide) (PNIPAM) are 
investigated for their capability to deliver drugs, encapsulate cells, 
and regenerate tissues. PNIPAM polymers are amphiphilic carrying 
amide groups (hydrophilic) and isopropyl groups (hydrophobic) 
with the LCST at around 32 °C. The LCST of the PNIPAM can be 
modified by co-polymerizing it with hydrophilic/hydrophobic 
monomers. Co-polymerization of PNIPAM with more hydrophilic 
monomers raises the LCST, whereas with more hydrophobic 
monomers, the LCST tends to decrease. The hydrophilic monomers 
such as acrylic acid and propyl acrylic acid modify the LCST of 
PNIPAM closer to body temperature. Though PNIPAM has an 
appropriate LCST, the clinical utilization of these thermosensitive 
polymers and their derivatives are limited because of their bio-
incompatibility [69-72]. 
b. PEO/PPO based systems 
Poloxamers or PEO-PPO-PEO systems or Pluronics are tri-block 
copolymers whose thermoreversible behavior could be manipulated 
by varying the composition, molecular weight, and concentration at 
physiological temperatures. The amphiphilic nature of this polymer 
is due to the presence of hydrophilic ethylene oxide moiety and 
hydrophobic propylene oxide moiety in the structure. The varying 
physicochemical properties of polyethylene and polypropylene 
make the poloxamer block to exhibit specific gel-like properties. The 
temperature rise induces a micelle formation, where the moderately 
hydrophilic PEO chain of the poloxamer linked with the water 
molecules forms a shell around the hydrophobic PPO chain wrapped 
into it as an inner core. However, the micelle formation is also 
dependent on the solution concentration. When the solution 
concentration exceeds the critical micelle concentration, the micelle 
is further entrapped, accumulated, and assembled due to various 
forces between the micelles. The gelation of poloxamer occurs with 
an increase in temperature, allowing them to be utilized as a 
thermo-sensitive in-situ gel matrix. PEO/PPO copolymers hydrogels 
attract more consideration due to their thermoresponsive behavior 
and biocompatibility. However, their use is limited clinically as they 
are non-biodegradable in vivo and need to dilute by the body fluid 
after infusion, which cannot be accomplished over the long term 
[27]. 
c. PEG/PLGA based system 
Co-polymerization of polyethylene glycol (PEG) with biocompatible 
polyesters delivers enticing hydrogel systems. The thermosensitive 
behavior of the PEG/PLGA system can be modulated by altering the 
length of hydrophobic polyester and PEG block significantly. PLGA-
PEG-PLGA tri-block copolymer has become a more fascinating 
thermosensitive material due to its in-toxicity, biocompatibility, and 
biodegradability. The sol-gel transition of PLGA-PEG-PLGA tri-block 
polymer is majorly due to the micelle formation which is driven by 
hydrophobic forces [73]. The biodegradability and thermoresponsive 
behavior of amphiphilic PEG/PLGA block copolymers have attracted 
special interest in the delivery of bioactive materials.  
Approaches and drug delivery system 
The thermosensitive hydrogels are most widely administered via 
subcutaneous, transdermal and mucosal routes [74-76].  
Subcutaneous drug delivery 
Unlike implants, the thermosensitive injectable hydrogels can 
achieve localized delivery without the requirement of invasive 
surgical procedures for insertion/removal of the drug delivery 
system. These in-situ systems release the drug in a sustained 
manner by undergoing a sol-gel transition at a physiological 
temperature [77]. If the polymer concentration is above the critical 
gel concentration (CGC), a gel phase will appear [78]. Subcutaneous 
drug delivery offers several advantages such as reduced systemic 
toxicity, improved patient compliance, ease in administration [79, 
80]. Gong et al. synthesized a novel in-situ thermosensitive 
composite hydrogel based on PCL-PEG-PCL copolymer and pluronic 
F127 for the controlled release of chemotherapeutic drugs [81]. 
Subcutaneous delivery of thermosensitive PEO-PPO-PEO tri-block 
polymers synthesized by Cohn et al. was reported to have long-term 
stability and enhanced mechanical strength [82]. For successful 
delivery of liposomes, nanoparticles, and microspheres, an in-situ 
thermo-sensitive hydrogel approach would be beneficial [83]. Yang 
et al. demonstrated that a mixed micelle gel prepared by adding a 
surfactant and thermosensitive polymer can improve the solubility, 
stability, and drug release characteristics [84]. Chen et al. found that 
paclitaxel-loaded hydrogel released the drug over 21 d in the 
subcutaneous tissue and successfully suppressed tumor growth in a 
rat model [85]. The sol-gel transition of thermo-sensitive hydrogel 
given through a subcutaneous route is represented in fig. 1. 
 
 
Fig. 1: This schematic diagram represents the sol-gel transition 
of thermo-sensitive hydrogel given through the subcutaneous 
route and its various applications 
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Transdermal drug delivery 
The transdermal route is considered to be a potential site to achieve 
systemic delivery of drugs. The major advantages of this route 
include termination of drug release at any moment is possible by 
simple removal of the device, controlled release of a drug over a 
longer duration, and avoidance of first-pass metabolism [86]. The 
limitation of this route is, only fewer drugs satisfy the 
physiochemical requirements (low dose, short half-life, low 
molecular weight, partition coefficient from 1.0 to 4.0) to permeate 
through the skin [87]. Gong et al., developed sustained-release in-
situ curcumin loaded PEG-PCL-PEG thermosensitive hydrogel to 
promote wound healing [88]. The thermo-sensitive sol-gel activity 
helps the system to adhere to wounds at skin temperature [89]. 
Ocular drug delivery 
The ocular route is the most efficient route for topical administration 
of drugs that can cause systemic side effects. The ocular drug delivery 
system offers better bioavailability and increased drug residence time 
[77]. The ability to deliver liquid and semisolid dosage form via ocular 
route makes in-situ forming hydrogel attractive for ocular drug 
delivery. Cohen et al. developed a prolonged release in-situ alginate gel 
with higher gluconic content for ophthalmic delivery of pilocarpine, 
which reduces intraocular pressure over 10 h, whereas pilocarpine 
solution act for the lesser duration (3 h) [86]. In vitro studies of 
oxytetracycline inserts on the rabbit eye showed a prolonged release 
of a drug over several days. Xi et al. reported a complete release of the 
drug (in 25 d) from mitomycin C loaded pluronic F 127 and poly (tri-
methylene carbonate) thermosensitive hydrogel [90]. 
Rectal drug delivery 
The rectal route is considered to be the most important route for the 
drugs which undergo extensive first-pass metabolism. Though the 
administered dosage form offers considerable therapeutic efficiency 
in this route, the patient acceptability is poor due to the discomfort 
associated with the administration. The preferred dosage form for 
rectal administration is conventional suppositories, which are solid 
at room temperature and melts/softens at body temperature. The 
controlled release of the drug, retention of the dosage form in a 
specific site of the rectum, migration of dosage form upward to the 
colon could not be achieved with the conventional suppositories 
[86]. Ryu et al. reported that the bioavailability of the propranolol is 
increased in rats, following the incorporation of thermo-sensitive, 
mucoadhesive polymers like poloxamer into the conventional 
suppositories. Similarly, incorporation of other mucoadhesive 
polymers such as polycarbophil and sodium alginate into 
suppositories increased the bioavailability of propranolol to 82.3 % 
and 84.7 %, respectively, with the highest mucoadhesive property 
and negligible intrarectal movement [91]. Xyloglucan, a thermo-
sensitive gel having an intrinsic mucoadhesive property is being 
investigated over the past two decades for rectal administration of 
drugs. Xyloglucan transforms into a gel at physiological temperature. 
Studies showed that indomethacin-loaded xyloglucan gel 
administered in rabbits via rectal route have well-controlled in vivo 
plasma concentration and time profiles when compared to the 
commercial suppositories containing indomethacin without 
compromising the bioavailability [92]. 
Sublingual drug delivery 
The sublingual route is the most promising route for the drugs 
which undergo extensive degradation by the gastrointestinal 
enzymes. In this route, the dosage form is kept beneath the tongue to 
deliver the drug directly into the blood vessels, thus helps in 
achieving high bioavailability by overcoming the first-pass 
metabolism [93]. The major limitations associated with this route 
are shorter mean residence time, smaller area for absorption, 
inadvertent swallowing of dosage form, and oral mucosal irritation 
[94]. The polymers like chitosan/dextran cross-linked with other 
polymers to obtain a thermosensitive hydrogel suitable for 
sublingual formulations [95]. Among the various polymers, PNIPAM 
has been extensively used in the preparation of thermo-responsive 
chitosan/dextran-based cross-linked copolymers for sublingual 
delivery [96]. Almeida et al. demonstrated the effect of temperature 
on drug release from thermo-responsive OndansetronTM 
Buccal drug delivery 
sublingual 
films. It was reported that the Ondansetron release is retarded at 37 
°C compared to its release at room temperature due to the increased 
degree of gel cross-linking [97]. 
The buccal mucosa is an attractive target for the administration of 
the majority of pharmaceuticals [98]. The buccal mucosa is highly 
vascularized, thus allowing the drug to enter directly into the 
systemic circulation. The key benefits of buccal drug delivery include 
patient acceptability, cost-effectiveness, avoidance of gastro-
intestinal degradation, bypassing first-pass metabolism, rapid onset 
of action, and increased bioavailability [99]. Poloxamer, a thermo-
sensitive hydrogel, has gained a special interest in buccal drug 
delivery owing to their sol-gel transition behavior with the response 
to temperature. Sandri et al. developed an in-situ thermo-sensitive 
buccal spray composed of poloxamer 407 (PF 127) and sodium 
alginate for the delivery of platelet lysate towards the treatment of 
oral mucositis. The poloxamer/sodium alginate spray is fluid at 
room temperature and rapidly forms a gel at 34 °C-35 °C [100]. The 
poloxamer 407 (PF127)/polyethylene oxide (PEO) composite 
hydrogel showed a prolonged release of the drug. The rate at which 
the drug is released from the PF127/PEO system was highly 
dependent on the concentration of PEO. The increase in the PEO 
concentration retarded the drug release and the steady-state 
concentration is achieved [101, 102].  
Applications involved in thermosensitive hydrogel 
The thermosensitive hydrogel is a very good candidate for many 
biomedical applications owing to their biocompatibility and their close 
resemblance with the extracellular matrix. Some of the typical 
applications of thermo-sensitive hydrogels include tissue engineering, 
wound healing, soft contact lenses, and sensors. Hydrogels are widely 
used for complex applications such as controlled drug delivery and 
tissue engineering rather than simple contact lenses. Some prominent 
examples of thermo-sensitive hydrogels in cancer therapy, protein 
delivery, gene therapy, tissue regeneration, and other therapeutic 
areas [27, 103] are discussed as follows. 
Cancer therapy 
Traditional chemotherapeutic drugs are cytotoxic and cause 
systemic toxicity more often. Localized delivery of chemotherapeutic 
drugs in a controlled manner offers better targeting and a longer 
duration of action, considered to be a potential approach for the 
treatment of cancer. Thermosensitive hydrogels as a drug delivery 
agent can allow the localized administration of a chemotherapeutic 
drug, thereby reducing their systemic side effects and increasing 
their efficacy. Thermosensitive hydrogels also offer controlled 
release of chemotherapeutic drugs at the tumor site [104, 105]. The 
use of thermosensitive hydrogels in humans for cancer therapy is 
still under investigation. The major hindrance in thermosensitive 
hydrogel-based cancer therapy, especially with pluronic polymers, is 
the dramatic change in the tumor cellular response to sensitizing the 
multi-drug resistance [105]. Cho et al. used thermosensitive poly 
(organophosphazene) as a vehicle for the controlled delivery of 
angiogenic inhibitor 2-methoxy-estradiol to limit the oxygen and 
nutrient supply to the tumor cell to suppress the tumor growth 
[106]. Chitosan-based thermosensitive hydrogels are extensively 
used to deliver the chemotherapeutic and immuno-therapeutic 
agents for cancer treatment. Han et al. developed intra tumoral 
Doxorubicin and Vaccinia virus vaccine (Sig/E7/lAMP-1) loaded 
thermosensitive chitosan-based hydrogel for the treatment of 
tumor. This combination neither decreased and nor increased the 
tumor-specific CD8+T cells up to 60 d. The survival rate of the 
tumor-bearing mice was significantly increased [107].  
Tissue regeneration 
Tissue engineering has gained special attention in the field of 
biomedical research due to its extensive application such as 
regeneration of functional tissues and delivery of bioactive 
components including drugs and growth factors. Thermosensitive 
hydrogels are found to be a promising candidate for the delivery of 
bioactive molecules and stem/progenitor cells needed for efficient 
tissue regeneration [108]. A thermosensitive hydrogel that is 
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capable of delivering growth factors and cells was developed by 
Guan et al. Angiogenesis is the most important requirement for 
tissue regeneration as it can ensure the nutrient/oxygen supply. 
Thermosensitive hydrogels are considered to be an effective 
delivery vehicle for angiogenic growth factors to stimulate 
angiogenesis in engineered tissues [109]. 
Gene therapy and protein delivery 
Proteins have gained special attention due to their excellent activity. 
However, they are more susceptible to environmental changes such as 
enzymes, pH, and temperature. Thermosensitive hydrogels are widely 
investigated for the delivery of proteins and growth factors due to 
their ability to control, sustain, and achieve optimal doses at local sites 
for effective tissue regeneration and repair. Thermosensitive 
hydrogels, a carrier for the protein delivery has several advantages 
such as uniform dispersion of protein in three-dimensional networks 
to prevent aggregation, precipitation, and inactivation, avoidance of 
denaturation of proteins during preparation, storage, and delivery by 
forming a protective layer to isolate it from environment, and 
controlled/sustained release of proteins [110]. Chen et al. developed 
vascular endothelial growth factor (VEGF) loaded injectable 
thermosensitive poly (D, L-lactic-co-glycolic acid)-b methoxy poly 
(ethylene glycol) (PLGA-MPEG) hydrogel for inducing 
neovascularization and bone regeneration [111]. 
Other application of thermosensitive hydrogels 
Thermosensitive hydrogels have enormous potential in several 
applications including wound care, cosmetology, etc. Intranasal 
delivery of thermosensitive hydrogels offers efficient systemic drug 
delivery and has the potential to bypass the blood-brain barrier by 
altering the permeability in the nasal cavity [112, 113]. 
Thermosensitive hydrogel allows heat dissipation, mimicking the 
biological sweating phenomenon [114]. Thermosensitive hydrogels 
are excellent carriers for the delivery of various biotherapeutic 
molecules as it can protect the incorporated cells and release them 
in a controlled manner [27]. 
  
Table 1: Summary of various thermosensitive hydrogels 
 Methods Polymers Drugs Formulation Treatment Reference 
Thin-layer evaporation Chitosan, Poloxamer Opiorphin Liposomes Liver cancer [115] 
Ammonium sulfate sodium method Carbopol, HPMC Doxorubicin Liposomes Liver cirrhosis [116] 
Emulsion evaporation method Chitosan, gelatin Curcumin Nanoparticle glaucoma [117] 
Melt emulsification method MPEG-PCL Docetaxel Nanoparticle Anti-ovarian cancer [118] 
Emulsification and solvent 
diffusion method 
HPMC, Pluronic-F 127 Sertoconazole Nanostructured 
lipid carrier 
Fungal keratitis [119] 
Hot emulsification method Chitosan Methotrexate Nanotubes Control tumor cell growth [120] 
Ethanol injection method Poloxamer 407, HPMC 
K100, Carbopol 934 
Zolmitriptan Nanoethosomes Treat headache disorders [121] 
Simple thin-film method Pluronic F-127 
andPluronic L 121 
Doxorubicin 
and Docetaxel 
Micelles Treat tumor [122] 
Rotary evaporation sonication 
technique 
Pluronic F-127 Insulin Transfersomes Treat diabetes mellitus [123] 
Emulsion cross-linking method Chitosan, PF-127 Lorazepam Microsphere Treat epilepsy [124] 
Fluorescence imaging method Amphiphilic 
copolymer 
Paclitaxel Free drug Intraperitoneal chemotherapy 
of carcinomatosis 
[125] 
Wang's method Hydroxy-butyl 
chitosan 
Dopamine Free drug Hemostasis [126] 
 
CONCLUSION 
Thermo-sensitive hydrogels based on natural and synthetic polymers 
exhibit lower critical solution temperature, low inflammatory 
response, biocompatibility, biodegradability, and mechanical 
properties suitable for various applications such as cancer therapy, 
protein delivery, gene delivery, tissue regeneration, and wound care. 
The route of administration and physiochemical properties of the drug 
has an important effect on the selection of thermo-sensitive polymers. 
Commercially available and FDA approved PF-127 is the most used 
thermo-sensitive polymer to date. Evidence from various in vitro and 
in vivo studies showed that existing thermo-sensitive hydrogels 
exhibits reduced cell viability and reduced capability to deliver the 
cells to the target tissues. However, with the appropriate 
experimentation, these limitations could be easily addressed. On the 
other hand, the properties of thermo-sensitive hydrogel should be 
improved to enable its usage in clinical practice. 
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